¼òÒªÃèÊö£ºÎ¸Ö¬Ã¸(³¢±õ±Ê¹ó)ÖØ×éµ°°×(±á³Ü³¾²¹²Ô£¬ÈË)»º³åÒº³É·Ý£ºÁ×ËáÑλº³åÒº£¨pH7.4£¬º¬ÓÐ 0.01% SKL, 1mM DTT, 5% TrehaloseºÍProclin300.£©
²úÎï·ÖÀà
Product Category²õ¾±²µ³¾²¹/²¹³¾±ð°ù²õ³¦´Ç½ø¿ÚÊÔ¼Á
Ïà¹ØÎÄÕÂ
Related ArticlesÏêϸ½éÉÜ
θ֬ø(LIPF)ÖØ×éµ°°×(Human£¬ÈË)
ÉÌÆ·ÊôÐÔ£º
²úÎïÃû³Æ | ÎïÖÖ | ÐͺŠ|
θ֬ø(LIPF)ÖØ×éµ°°×(Human£¬ÈË) | Homo sapiens (Human£¬ÈË) | GOY-01D712 |
Ó¢ÎÄÃû³Æ£ºRecombinant
Lipase, Gastric (LIPF)
HGL; HLAL; Gastric lipase
øÓ뼤ø£º
ÎïÖÖ | Homo sapiens (Human£¬ÈË) |
À´Ô´ | Ժ˱í´ï |
ËÞÖ÷ | E.coli |
ÑÇϸ°û¶¨Î» | n/a |
Ô¤²â·Ö×ÓÁ¿ | 73.2kDa |
ʵ¼Ê·Ö×ÓÁ¿ | 73.2kDa(²îÒì·ÖÎöÇë²ÎÔÄ˵Ã÷Êé) |
Ƭ¶ÎÓë±êÇ© | Leu20~Lys398 with N-terminal His and GST Tag |
»º³åÒº³É·Ý | Á×ËáÑλº³åÒº£¨pH7.4£¬º¬ÓÐ 0.01% SKL, 1mM
DTT, 5% TrehaloseºÍProclin300.£© |
ÐÔ×´ | ¶³¸É·Û |
´¿¶È | > 95% |
ÄÚ¶¾ËØˮƽ | <1.0EU/¦Ìg(LAL·¨²â¶¨) |
µÈµçµã |
|
Ó¦ÓÃ | Positive Control; Immunogen; SDS-PAGE; WB. |
¹æ¸ñ | 10¦Ìg50¦Ìg200¦Ìg1mg5mg |
ÕæºË±í´ïϵͳµÄÖØ×éµ°°×±í´ï²½Ö裺
a. Ñ¡Ôñ±í´ïÔØÌåºÍËÞÖ÷ϸ°û£¨³£ÓõÄCHOºÍHEK293£©
b. ±í´ïÔØÌåµÄ¹¹½¨
c. ÎÞÄÚ¶¾ËصÄÖÊÁ£³éÌá
d. ϸ°û˲ʱתȾ
e. ±í´ïСÊÔ£¬Ìõ¼þÓÅ»¯
f. ±í´ï·ÖÎöºÍ¼ø¶¨£¨SDS-PGAEºÍWB£©
g. ´óÁ¿±í´ï
h. Ç׺ʹ¿»¯
i. ¼ì²âºÍ¼ø¶¨
Ժ˱í´ïϵͳµÄÖØ×éµ°°×±í´ï²½Ö裺
a. Ñ¡Ôñ±í´ïÔØÌå
b. ÃÜÂë×ÓÓÅ»¯
c. »ùÒòºÏ³É/ÑÇ¿Ë¡
d. ת»¯±í´ï¾úÖê
e. µ°°×±í´ïСÊÔ·ÖÎö
f. Èç¹ûµ°°×¿ÉÈÜ£¬µ°°×Ç׺ʹ¿»¯
g. Èç¹ûµ°°×²»¿ÉÈÜ£¬ÔòÐèÒª±ä¸´ÐÔÀ´ÖƱ¸¿ÉÈܵ°°×¡£
h. ¼ø¶¨£¬°üÀ¨SDS-PAGEºÍWB¼ø¶¨
²úÎï×Éѯ
µç»°
΢ÐÅɨһɨ